brentm77
DIS Veteran
- Joined
- Jan 17, 2013
- Messages
- 2,056
I read the breakthroughs were all prior to 14 days post secondary vaccination. I haven't had a chance to look at the data. Do you know if that is true?As I had cautioned previously, the South African variant was able to get through Pfizer's two doses as well:
https://www.cnbc.com/2021/04/11/cov...-through-pfizer-vaccine-in-israeli-study.html
Here is a link to the study itself:
https://www.medrxiv.org/content/10.1101/2021.04.06.21254882v1
The highlights:
* This study is sourced from the real-life data in Israel.
* The researchers were expecting to see just one (1) case of the South African variant in the vaccinated group using its published efficacy numbers. They found 8 actual cases.
* For each expected case of the UK variant in the vaccinated group, they found 2.6 actual cases.
So, the real-life data is suggesting that the current mRNA vaccines will need to be boosted. And it also means the restrictions will have to remain in place in most international travel.
The study doesn't talk about severity and hospitalization, and I am hoping the results are similar to those from other vaccines - that is, the vaccines work. And that's the truly actionable metric now - at least until the boosters arrive.
Last edited: